APPLIED GENETIC TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-15: Reporting owner VANLENT ANNE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-15: Reporting owner Rosen James; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-15: Reporting owner Magovcevic Ivana; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-15: Reporting owner HURWITZ EDWARD; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-15 | VANLENT ANNE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-11-15 | Rosen James Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-11-15 | Magovcevic Ivana Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-11-15 | HURWITZ EDWARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-11-15 | Aliski William Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-11-15 | Koenig Scott Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.90 exercise price | 2018-11-19 | |
| 2018-09-20 | Aliski William Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $4.40 exercise price | 2018-09-24 | |
| 2018-07-25 | VANLENT ANNE Director | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.25 exercise price | 2018-07-30 | |
| 2018-07-25 | Rosen James Director | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.25 exercise price | 2018-07-30 | |
| 2018-07-25 | Magovcevic Ivana Director | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.25 exercise price | 2018-07-30 | |
| 2018-07-25 | HURWITZ EDWARD Director | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.25 exercise price | 2018-07-30 | |
| 2018-07-25 | Koenig Scott Director | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.25 exercise price | 2018-07-30 | |
| 2018-07-25 | VANLENT ANNE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Rosen James Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Magovcevic Ivana Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | HURWITZ EDWARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Koenig Scott Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Potter Stephen W Officer (VP and Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,000 85,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Sullivan William A. Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Shearman Mark S Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,000 85,000 owned after | $4.25 exercise price | 2018-07-27 | |
| 2018-07-25 | Washer Susan B. Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $4.25 exercise price | 2018-07-27 |